Belgium and World Health Organization Deepen Strategic Partnership to Advance Universal Health Coverage and Global Health Security

GENEVA — In an intensive three-day diplomatic and technical engagement, senior representatives from the Kingdom of Belgium and the World Health Organization (WHO) concluded a high-level strategic dialogue aimed at reinforcing their long-standing multilateral partnership. The consultations, which brought together delegates from the Belgian federal government as well as the Flemish and Walloon regional governments, focused on aligning bilateral development cooperation priorities with the WHO’s evolving global health mandates. Against the backdrop of a volatile geopolitical climate and compounding international health emergencies, the dialogue yielded renewed commitments to universal health coverage (UHC), health-systems strengthening, and equitable access to essential medicines, vaccines, and health technologies.

The Belgian delegation was led by H.E. Christophe Payot, Ambassador and Permanent Representative of Belgium to the United Nations and other international organizations in Geneva. The delegation included key policymakers, technical advisors, and diplomatic officials, reflecting a whole-of-government approach to international health cooperation. On the opposing side, WHO was represented by senior leadership and technical experts hailing from Geneva headquarters, alongside regional representatives from the WHO Regional Office for Africa and the WHO Regional Office for Europe.

This comprehensive meeting builds upon a rich history of collaboration between the Belgian state and the United Nations health agency. Over the decades, Belgium has cemented its reputation as a reliable, predictable, and progressive donor in international health development, frequently championing equitable access, human rights-based health interventions, and robust multilateral frameworks. The 2025 strategic dialogue served not only as a routine checkpoint for ongoing multi-year funding agreements but also as a crucial forum for strategic realignment following the strategic priorities highlighted during the Belgian presidency of the Council of the European Union in 2024.

Background Context and Evolution of the Belgium-WHO Partnership

The modern architecture of global health is increasingly tested by overlapping crises, ranging from persistent post-pandemic vulnerabilities to climate-driven disease outbreaks and protracted humanitarian emergencies. Within this complex ecosystem, the partnership between Belgium and the WHO has served as a cornerstone for targeted interventions in fragile and low-income settings.

Historically, Belgian development cooperation—overseen by the Directorate-General for Development Cooperation and Humanitarian Aid (DGD)—has prioritized fragile states, human development, and sexual and reproductive health and rights (SRHR). By channeling flexible multi-year funding through the WHO, Belgium has enabled the agency to deploy rapid technical assistance, strengthen indigenous health workforces, and support national ministries of health in drafting sustainable, locally owned health policies.

The timeline of recent engagements underscores a deepening institutional trust. Following joint priority-setting exercises in 2021, the partnership intensified its focus on primary health care as the primary vehicle for achieving universal health coverage. The COVID-19 pandemic further catalyzed this cooperation, exposing severe structural inequities in the global distribution of medical countermeasures. In response, Belgium significantly bolstered its financial and diplomatic backing for WHO-led initiatives designed to bridge the gap between high-income nations and the Global South regarding vaccine manufacturing capacity, regulatory harmonization, and supply chain resilience.

Accelerating Equitable Access to Vaccines, Medicines, and Health Technologies

A central pillar of the three-day dialogue was a rigorous review of the Access to Medicines programme, a flagship initiative heavily funded by Belgium. Participants evaluated the tangible impacts of the program across various developing economies, scrutinizing both successes and operational bottlenecks.

To provide a concrete illustration of field-level dynamics, WHO technical experts presented a detailed case study on the implementation of the Access to Medicines initiative in Senegal. The presentation highlighted the hurdles of last-mile delivery, regulatory capacity constraints, and the complexities of establishing sustainable local production facilities for pharmaceuticals and biologicals. Discussions emphasized that achieving long-term success requires sophisticated market-shaping strategies. Without interventions that balance affordability with market viability for local manufacturers, global health initiatives risk collapsing once external donor funding subsides.

The discourse extended into broader discussions on local manufacturing hubs in Africa and other developing regions. Both delegations concurred that technology transfer, intellectual property flexibilities, and specialized workforce training are indispensable prerequisites for mitigating future supply chain shocks. By fostering regional manufacturing ecosystems, low- and middle-income countries can insulate themselves against export bans and hoarding behaviors by wealthy nations during acute global health crises.

Health Emergencies and Pandemic Prevention, Preparedness, and Response

With the global health community actively navigating the lessons of the COVID-19 pandemic, the dialogue naturally gravitated toward the architecture of health emergency prevention, preparedness, response, and resilience (PPPR). Delegations engaged in substantive exchanges concerning the ongoing negotiations surrounding the global pandemic agreement, underlining the necessity of binding legal commitments to ensure transparency, equitable countermeasures allocation, and mutual accountability.

The discussions did not remain purely theoretical. WHO officials presented operational briefings on the organization’s frontline work in acute crisis zones, focusing specifically on health emergency responses in Gaza. The presentation highlighted the staggering challenges faced by healthcare workers operating in active conflict zones, where medical infrastructure has been systematically degraded, and supply lines severely restricted.

Furthermore, the agenda addressed the escalating biological risks associated with zoonotic spillover events, antimicrobial resistance (AMR), and the accelerating interface between environmental degradation and infectious disease emergence. The implementation of the "One Health" approach—recognizing the interconnection between human, animal, and environmental health—was reaffirmed as a non-negotiable framework for future risk mitigation and surveillance strategies.

Advancing Universal Health Coverage and Primary Health Care

Universal health coverage remains the ultimate north star for both the WHO and Belgian development policy. During dedicated sessions on the UHC-Partnership, participants reviewed the cumulative results achieved between 2021 and 2024 across Belgium’s priority partner countries.

A granular review of the Democratic Republic of Congo (DRC) served as a primary case study. Representatives analyzed the operational challenges of integrating vertical disease programs into cohesive primary health care systems within a vast and politically complex nation. The dialogue also underscored the integration of mental health services into primary care frameworks, reflecting a growing international consensus that psychological well-being is inextricably linked to overall community health and economic productivity.

Beyond general health systems, the review encompassed specialized collaborative portfolios supported by Belgian funding, notably programs addressing Neglected Tropical Diseases (NTDs) and Sexual, Reproductive Health and Rights (SRHR). Both parties underscored the imperative of maintaining an evidence-based approach in these contentious or underfunded sectors, ensuring that policy decisions are driven by epidemiological data and human rights principles rather than political shifts.

Official Responses and Diplomatic Perspectives

The high-level nature of the dialogue allowed for candid evaluations of the partnership from both administrative and political leadership.

Mr. Koen Van Acoleyen, Minister Counselor at the Permanent Representation of Belgium to the UN, emphasized the value of direct engagement with the agency’s technical personnel. "After listening to the leaders and experts of WHO, we now better understand how they are navigating these challenging times," Mr. Van Acoleyen remarked. "We are honored that we can walk this road together."

Dr. Catharina Boehme, WHO Assistant Director-General for External Relations and Governing Bodies, expressed deep appreciation for Belgium’s steadfast multilateralism, noting the unique strength derived from the participation of both federal and regional authorities. "We thank you for your support, honesty, and strong engagement for global health," Dr. Boehme stated. "Your efforts in supporting our work in Mozambique and Senegal are clear examples of the crucial work we accomplish together."

Echoing these sentiments, Mr. Dirk Brems, Director of Thematic and Multilateral Cooperation at the Directorate-General Development Cooperation and Humanitarian Aid, highlighted the tangible validation the dialogue provided to Belgian taxpayers and policymakers. "We recognize WHO as a trustworthy partner in global health. We felt proud hearing how crucial our support is to the Organization and how it is having a positive impact at country, regional, and global levels," said Mr. Brems. "It’s important we continue these discussions as we tread uncharted territories, and we look forward to working together for strong and sustained multilateralism."

Looking Forward: The 14th General Programme of Work (GPW14)

As the three-day strategic dialogue drew to a close, attention shifted toward the future horizon. The delegations outlined parameters for the upcoming Belgium-WHO collaboration framework and multi-year funding agreements, initiating steps toward a renewed WHO-Belgium Country Cooperation Strategy.

The strategic alignment is explicitly designed to support the overarching ambitions of the WHO’s 14th General Programme of Work (GPW14). A core consensus emerged around the principle that universal health coverage and health-systems strengthening must remain at the very heart of GPW14 priorities. By embedding these principles into WHO’s ongoing institutional prioritization work, Belgium and the WHO aim to ensure that global health investments yield measurable, sustainable impacts on the ground.

Broader Impact and Policy Implications

The renewal and deepening of the Belgium-WHO partnership carry significant implications for the broader global health architecture. At a time when traditional multilateral institutions face severe skepticism, donor fatigue, and competing geopolitical pressures, the continued commitment of mid-sized sovereign donors like Belgium provides a vital stabilizing force.

By prioritizing flexible funding, local capacity building, and evidence-based primary health care, Belgium models an enlightened approach to international development cooperation that resists the temptation of short-term, politically expedient vertical programming. As the international community prepares for future health shocks, the reinforced alliance between Brussels and Geneva offers a resilient blueprint for how bilateral commitment and multilateral expertise can effectively converge to protect and promote global public health.